1.
|
NAME
OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
RTW
Investments, LP
|
|
|
2.
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
3.
|
SEC
USE ONLY
|
4.
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware
|
|
|
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5.
|
SOLE
VOTING POWER
1,682,611*
|
6.
|
SOLE
DISPOSITIVE POWER
1,682,611*
|
|
|
7.
|
SOLE
DISPOSITIVE POWER
0
|
|
|
8.
|
SHARED
DISPOSITIVE POWER
1,682,611*
|
|
|
9.
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,682,611*
|
|
|
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
[ ]
|
|
|
11.
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.12%*
|
|
|
12.
|
TYPE
OF REPORTING PERSON (SEE INSTRUCTIONS)
PN,
OO, IA
|
1.
|
NAME
OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Roderick
Wong
|
|
|
2.
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
3.
|
SEC
USE ONLY
|
4.
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States of America
|
|
|
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5.
|
SOLE
VOTING POWER
0
|
6.
|
SOLE
DISPOSITIVE POWER
1,682,611*
|
|
|
7.
|
SOLE
DISPOSITIVE POWER
0
|
|
|
8.
|
SHARED
DISPOSITIVE POWER
1,682,611*
|
|
|
9.
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,682,611*
|
|
|
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
[ ]
|
|
|
11.
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.12%*
|
|
|
12.
|
TYPE
OF REPORTING PERSON (SEE INSTRUCTIONS)
IN,
HC
|
Item
1.
|
(a).
|
Name
of Issuer:
Bovie
Medical Corporation
|
|
(b).
|
Address
of issuer’s principal executive offices:
|
|
|
4
Manhattanville Road, Suite 106
|
|
|
Purchase,
NY 10577
|
Item
2.
|
(a).
|
Name
of person filing:
|
|
|
RTW
Investments, LP
|
|
|
Roderick
Wong
|
|
(b).
|
Address
or principal business office or, if none, residence:
|
|
|
RTW
Investments, LP
250
West 55th Street, 16th Floor
|
|
|
Suite
A
|
|
|
New
York, New York 10019
|
|
|
Roderick
Wong
|
|
|
c/o
RTW Investments, LP
250
West 55th Street, 16th Floor
|
|
|
Suite
A
|
|
|
New
York, New York 10019
|
|
(c).
|
Citizenship:
|
|
|
RTW
Investments, LP – Delaware
|
|
|
Roderick
Wong – United States of America
|
|
(d).
|
Title
of class of securities:
|
|
|
Common
Stock, $0.001 par value
|
|
(e).
|
CUSIP
No.:
|
|
|
10211F100
|
Item
3.
|
If
this statement is filed pursuant to §240.13d-1(b) or 240.13d.2(b) or (c), check whether the person filing is a:
|
|
|
|
|
|
|
N/A
|
|
|
|
|
|
Item
4.
|
|
Ownership.
|
|
|
|
|
|
|
|
Provide
the following information regarding the aggregate number and percentage of the class
of securities of the issuer identified in Item 1.
|
|
(a)
|
Amount
beneficially owned:
|
|
|
|
|
|
RTW
Investments, LP – 1,682,611*
|
|
|
Roderick
Wong – 1,682,611*
|
|
|
|
|
(b)
|
Percent
of class:
|
|
|
|
|
|
RTW
Investments, LP – 5.12%*
|
|
|
Roderick
Wong – 5.12%*
|
|
|
|
|
(c)
|
Number
of shares as to which the person has:
|
|
(i)
|
Sole
power to vote or to direct the vote
|
|
|
|
|
|
RTW
Investments, LP – 0
Roderick
Wong – 0
|
|
|
|
|
(ii)
|
Shared power
to vote or to direct the vote
|
|
|
|
|
|
RTW
Investments, LP – 1,682,611*
Roderick
Wong – 1,682,611*
|
|
|
|
|
(iii)
|
Sole power
to dispose or to direct the disposition of
|
|
|
RTW
Investments, LP – 0
|
|
|
Roderick
Wong – 0
|
|
|
|
|
(iv)
|
Shared power
to dispose or to direct the disposition of
|
|
|
RTW
Investments, LP – 1,682,611*
|
|
|
Roderick
Wong – 1,682,611*
|
*
The shares of common stock (the “Shares”), of Bovie Medical Corporation. (the “Company”) reported herein
are held by two or more funds (together the “Funds”), which are managed by RTW Investments, LP (the “Adviser”).
The Adviser, in its capacity as the investment manager of the Funds, has the power to vote and the power to direct the disposition
of all Shares held by the Funds. Accordingly, for the purposes of Reg. Section 240.13d-3, the Adviser may be deemed to beneficially
own an aggregate of 1,682,611 Shares, or 5.12% of Shares deemed issued and outstanding as of October 30, 2017. Roderick Wong is
the Managing Partner of the Adviser. The beneficial ownership percentage reported herein is based on 32,860,785 voting Shares
issued and outstanding as of October 30, 2017, as disclosed in the Company’s Quarterly Report filed with the Securities
and Exchange Commission on November 3, 2017. This report shall not be deemed an admission that the Adviser, the Funds or any other
person is the beneficial owner of the securities reported herein for purposes of Section 13 of the Securities Exchange Act of
1934, as amended, or for any other purpose. Each of the reporting persons herein disclaims beneficial ownership of the Shares
reported herein except to the extent of the reporting person’s pecuniary interest therein.
Item
5. Ownership of Five Percent or Less of a Class.
If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the following [_].
N/A
Item
6. Ownership of More Than Five Percent on Behalf of Another Person.
If
any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from
the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates
to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company
registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund
is not required.
N/A
Item
7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent
Holding
Company or Control Person.
If
a parent holding company or control person has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item
3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding
company or control person has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification
of the relevant subsidiary.
N/A
Item
8. Identification and Classification of Members of the Group.
If
a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating
the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d-1(c)
or Rule 13d-1(d), attach an exhibit stating the identity of each member of the group.
N/A
Item
9. Notice of Dissolution of Group.
Notice
of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with
respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity.
See Item 5.
N/A
Item
10. Certification.
By
signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated:
January 9, 2018
RTW
Investments, LP
By:
/s/ Roderick Wong
Roderick
Wong, Managing Partner
Roderick
Wong
By:
/s/ Roderick Wong
Roderick
Wong, Individually
The
original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If
the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner
of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the
statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated
by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.
Note.
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See s.240.13d-7
for other parties for whom copies are to be sent.
Attention.
Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).
Exhibit
1
Joint
Filing Statement Statement
Pursuant
to Rule 13d-1(k)(1)
The
undersigned hereby consent and agree to file a joint statement on Schedule 13G under the Securities Exchange Act of 1934, as amended,
with respect to the common stock, $0.001 par value, of Bovie Medical Corporation. beneficially owned by them, together with any
or all amendments thereto, when and if appropriate. The parties hereto further consent and agree to file this Joint Filing Statement
pursuant to Rule13d-1(k)(1)(iii) as an exhibit to Schedule 13G, thereby incorporating the same into such Schedule13G.
This
Joint Filing Statement may be terminated by any of the undersigned upon written notice or such lesser period of notice as the
undersigned may mutually agree.
Dated:
January 9, 2018
RTW
Investments, LP
By:
/s/ Roderick Wong
Roderick
Wong, Managing Partner
Roderick
Wong
By:
/s/ Roderick Wong
Roderick
Wong, Individually